Diabetes 69 (7), 14391450
What's Next: The TRIUMPH Program and Regulatory Path TRIUMPH-4 is just one piece of a much larger puzzle
Availability and Sourcing Tirzepatide is FDA-approved and widely available through healthcare providers under the brand names Mounjaro (for Type 2 Diabetes) and Zepbound (for weight management)
Compounded versions of both medications cost significantly less, often $100 to $400 per month depending on the pharmacy and dose
And then, again, they should be able to access other medications if they aren't able to continue the GLP-1s after the pilot program
In June 2021, the FDA approved a higher-dose formulation of semaglutidemarketed under the brand name Wegovyspecifically for chronic weight management in adults with obesity or those who are overweight and have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol